Aberrant type 1 immunity drives susceptibility to mucosal fungal infections
Male
T-Lymphocytes
Mice
Receptors
Candida albicans
Medicine and Health Sciences
2.1 Biological and endogenous factors
Aetiology
Polyendocrinopathies, Autoimmune
Immunologic Surveillance
Inbred BALB C
Mucosal
Mice, Inbred BALB C
0303 health sciences
Interleukin-17
Candidiasis, Chronic Mucocutaneous
Candidiasis
Life Sciences
Middle Aged
3. Good health
Infectious Diseases
STAT1 Transcription Factor
Female
Infection
Genomics and Computational Biology Core
Adult
Adolescent
General Science & Technology
610
Chronic Mucocutaneous
Autoimmune Disease
Young Adult
Interferon-gamma
03 medical and health sciences
Animals
Humans
Immunity, Mucosal
JMG
Aged
Janus Kinases
Animal
Inflammatory and immune system
Interleukins
Immunity
Mouth Mucosa
Disease Models, Animal
Emerging Infectious Diseases
Polyendocrinopathies
Disease Models
Autoimmune
DOI:
10.1126/science.aay5731
Publication Date:
2021-01-14T20:06:30Z
AUTHORS (43)
ABSTRACT
Type 1 immunity gives fungi a foothold
Type 17 immune responses play a vital role against fungal infections of the mucosa. It remains unclear whether other types of immune responses can also contribute to host defense against these pathogens. The yeast
Candida albicans
prominently infects patients with autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy (APECED), an inherited disease caused by loss-of-function mutations in the
AIRE
gene. Break
et al.
report that the oral susceptibility of
Aire
-deficient mice to
C. albicans
is not due to aberrant type 17 responses. Rather, the overproduction of interferon-γ by local CD4
+
and CD8
+
T cells in these mice disrupts the epithelial barrier, which increases susceptibility to
C. albicans
invasion. Similar type 1 immune pathways are operational in APECED patients. Inhibition of interferon-γ or the JAK-STAT signaling pathway in mice ameliorates disease symptoms, suggesting potential future therapeutic interventions for certain classes of fungal disease.
Science
, this issue p.
eaay5731
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (74)
CITATIONS (123)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....